110 related articles for article (PubMed ID: 1912328)
1. Transformation of dopamine and alpha-methyldopamine by NG108-15 cells: formation of thiol adducts.
Patel N; Kumagai Y; Unger SE; Fukuto JM; Cho AK
Chem Res Toxicol; 1991; 4(4):421-6. PubMed ID: 1912328
[TBL] [Abstract][Full Text] [Related]
2. Hepatotoxicity of 3,4-methylenedioxyamphetamine and alpha-methyldopamine in isolated rat hepatocytes: formation of glutathione conjugates.
Carvalho M; Milhazes N; Remião F; Borges F; Fernandes E; Amado F; Monks TJ; Carvalho F; Bastos ML
Arch Toxicol; 2004 Jan; 78(1):16-24. PubMed ID: 14586543
[TBL] [Abstract][Full Text] [Related]
3. Glutathione and N-acetylcysteine conjugates of alpha-methyldopamine produce serotonergic neurotoxicity: possible role in methylenedioxyamphetamine-mediated neurotoxicity.
Bai F; Lau SS; Monks TJ
Chem Res Toxicol; 1999 Dec; 12(12):1150-7. PubMed ID: 10604863
[TBL] [Abstract][Full Text] [Related]
4. Metabolism is required for the expression of ecstasy-induced cardiotoxicity in vitro.
Carvalho M; Remião F; Milhazes N; Borges F; Fernandes E; Monteiro Mdo C; Gonçalves MJ; Seabra V; Amado F; Carvalho F; Bastos ML
Chem Res Toxicol; 2004 May; 17(5):623-32. PubMed ID: 15144219
[TBL] [Abstract][Full Text] [Related]
5. Effects of intracerebroventricular administration of 5-(glutathion-S-yl)-alpha-methyldopamine on brain dopamine, serotonin, and norepinephrine concentrations in male Sprague-Dawley rats.
Miller RT; Lau SS; Monks TJ
Chem Res Toxicol; 1996 Mar; 9(2):457-65. PubMed ID: 8839050
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, in vitro formation, and behavioural effects of glutathione regioisomers of alpha-methyldopamine with relevance to MDA and MDMA (ecstasy).
Easton N; Fry J; O'Shea E; Watkins A; Kingston S; Marsden CA
Brain Res; 2003 Oct; 987(2):144-54. PubMed ID: 14499958
[TBL] [Abstract][Full Text] [Related]
7. The toxicity of N-methyl-alpha-methyldopamine to freshly isolated rat hepatocytes is prevented by ascorbic acid and N-acetylcysteine.
Carvalho M; Remião F; Milhazes N; Borges F; Fernandes E; Carvalho F; Bastos ML
Toxicology; 2004 Aug; 200(2-3):193-203. PubMed ID: 15212815
[TBL] [Abstract][Full Text] [Related]
8. Neurotoxicity mechanisms of thioether ecstasy metabolites.
Capela JP; Macedo C; Branco PS; Ferreira LM; Lobo AM; Fernandes E; Remião F; Bastos ML; Dirnagl U; Meisel A; Carvalho F
Neuroscience; 2007 Jun; 146(4):1743-57. PubMed ID: 17467183
[TBL] [Abstract][Full Text] [Related]
9. Pro-oxidant effects of Ecstasy and its metabolites in mouse brain synaptosomes.
Barbosa DJ; Capela JP; Oliveira JM; Silva R; Ferreira LM; Siopa F; Branco PS; Fernandes E; Duarte JA; de Lourdes Bastos M; Carvalho F
Br J Pharmacol; 2012 Feb; 165(4b):1017-33. PubMed ID: 21506960
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of 5-(glutathion-S-yl)-alpha-methyldopamine following intracerebroventricular administration to male Sprague-Dawley rats.
Miller RT; Lau SS; Monks TJ
Chem Res Toxicol; 1995; 8(5):634-41. PubMed ID: 7548745
[TBL] [Abstract][Full Text] [Related]
11. Thioether metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine inhibit human serotonin transporter (hSERT) function and simultaneously stimulate dopamine uptake into hSERT-expressing SK-N-MC cells.
Jones DC; Lau SS; Monks TJ
J Pharmacol Exp Ther; 2004 Oct; 311(1):298-306. PubMed ID: 15169827
[TBL] [Abstract][Full Text] [Related]
12. Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species.
Spencer JP; Jenner P; Daniel SE; Lees AJ; Marsden DC; Halliwell B
J Neurochem; 1998 Nov; 71(5):2112-22. PubMed ID: 9798937
[TBL] [Abstract][Full Text] [Related]
13. "Ecstasy"-induced toxicity in SH-SY5Y differentiated cells: role of hyperthermia and metabolites.
Barbosa DJ; Capela JP; Silva R; Ferreira LM; Branco PS; Fernandes E; Bastos ML; Carvalho F
Arch Toxicol; 2014 Feb; 88(2):515-31. PubMed ID: 24177245
[TBL] [Abstract][Full Text] [Related]
14. The role of metabolism in 3,4-(+)-methylenedioxyamphetamine and 3,4-(+)-methylenedioxymethamphetamine (ecstasy) toxicity.
Monks TJ; Jones DC; Bai F; Lau SS
Ther Drug Monit; 2004 Apr; 26(2):132-6. PubMed ID: 15228153
[TBL] [Abstract][Full Text] [Related]
15. Neurotoxicity of "ecstasy" and its metabolites in human dopaminergic differentiated SH-SY5Y cells.
Ferreira PS; Nogueira TB; Costa VM; Branco PS; Ferreira LM; Fernandes E; Bastos ML; Meisel A; Carvalho F; Capela JP
Toxicol Lett; 2013 Feb; 216(2-3):159-70. PubMed ID: 23194825
[TBL] [Abstract][Full Text] [Related]
16. Role of metabolites in MDMA (ecstasy)-induced nephrotoxicity: an in vitro study using rat and human renal proximal tubular cells.
Carvalho M; Hawksworth G; Milhazes N; Borges F; Monks TJ; Fernandes E; Carvalho F; Bastos ML
Arch Toxicol; 2002 Oct; 76(10):581-8. PubMed ID: 12373454
[TBL] [Abstract][Full Text] [Related]
17. 2,5-Bis-(glutathion-S-yl)-alpha-methyldopamine, a putative metabolite of (+/-)-3,4-methylenedioxyamphetamine, decreases brain serotonin concentrations.
Miller RT; Lau SS; Monks TJ
Eur J Pharmacol; 1997 Apr; 323(2-3):173-80. PubMed ID: 9128836
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of methylenedioxymethamphetamine: formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct.
Hiramatsu M; Kumagai Y; Unger SE; Cho AK
J Pharmacol Exp Ther; 1990 Aug; 254(2):521-7. PubMed ID: 1974641
[TBL] [Abstract][Full Text] [Related]
19. Dopamine toxicity in neuroblastoma cells: role of glutathione depletion by L-BSO and apoptosis.
Stokes AH; Lewis DY; Lash LH; Jerome WG; Grant KW; Aschner M; Vrana KE
Brain Res; 2000 Mar; 858(1):1-8. PubMed ID: 10700589
[TBL] [Abstract][Full Text] [Related]
20. Major metabolites of (+/-)3,4-methylenedioxyamphetamine (MDA) do not mediate its toxic effects on brain serotonin neurons.
McCann UD; Ricaurte GA
Brain Res; 1991 Apr; 545(1-2):279-82. PubMed ID: 1860050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
